Innovative RhythmStar® technology designed to improve cardiac monitoring for faster arrhythmia detection MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ — RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring […]
Other News
Caption Health Announces JAMA Cardiology Publication Showing Effectiveness of AI-Guided Ultrasound Software
Multicenter clinical study supported landmark FDA authorization of Caption Guidance software in February 2020 BRISBANE, Calif., Feb. 18, 2021 /PRNewswire/ — Caption Health, a leading medical artificial intelligence (AI) company providing AI guidance and interpretation for ultrasound, today announced the publication of the study that was the basis for the February 2020 authorization of Caption […]
Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results
SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2020. Recent Highlights Recognized revenue […]
Cytokinetics Names Muna Bhanji to Board of Directors
Appointment Adds to Board Expertise in Commercial Development and Market Access as Company Prepares for Further Corporate Development SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Muna Bhanji has been appointed to the company’s Board of Directors. Ms. Bhanji brings more than 30 […]
Aziyo Biologics Announces First Patient Enrolled in HEAL Study
SILVER SPRING, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the first patient enrolled in the HEAL Study, investigating the biologic and clinical […]
Swiss-based MedTech Startup EBAMed Appoints Marina Izzo as CEO
GENEVA–(BUSINESS WIRE)–EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022. Former CEO and co-founder, […]
Study Confirms Elucid’s AI Software Accurately Estimates Lesion-Specific Ischemia Compared to Standard of Care
BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, announced today the publication of new clinical data in the International Journal of Cardiology. The study, entitled “Coronary plaque assessment of Vasodilative capacity by CT angiography effectively estimates fractional flow reserve” demonstrates that Fractional Flow Reserve (FFR) […]
Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System
DUBLIN, Feb. 17, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians to immediately cease use of the device until further notice. In accordance with its commitment to patient safety – […]
Erin Michos, MD, MHS, FASPC is named Co-Editor-In-Chief of the American Journal of Preventive Cardiology
JACKSONVILLE, Fla., Feb. 17, 2021 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) is excited to announce that Erin Michos, MD, MHS, FASPC has accepted the position of Co-Editor-in-Chief of the American Journal of Preventive Cardiology (AJPC). Dr. Michos joins Nathan Wong, PhD, MPH, FASPC as a co-editor of AJPC, ASPC’s official journal that […]
BioCardia Announces Clinical Leadership Changes
SAN CARLOS, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced clinical leadership changes. Dr. Sujith Shetty who has been with the Company for almost two years in the capacity of Vice President of Clinical and Regulatory […]



